Five core ADME genes coding for phase II drug metabolism enzymes showed significant associations of their intratumoral expression levels with OS rates in cancers, including GSTP1, NAT1, UGT1A1, UGT2B15, UGT2B7 (Figure 3, Table 2). Here, NAT1 is linked to cancer.